BRIEF-Amgen announces positive top-line results from Xgeva (Denosumab) Phase 3 trial
October 20, 2016 at 16:46 PM EDT
* Amgen announces positive top-line results from Xgeva (Denosumab) Phase 3 trial for delay of bone complications in multiple Myeloma patients